Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HLX 71

Next Previous
X
Search
Drug Profile

HLX 71

Alternative Names: ACE2-Fc fusion protein; HLX-71; Recombinant Human Angiotensin-Converting Enzyme 2-Fc Fusion Protein; Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19

Latest Information Update: 15 Apr 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Henlius Biotech
  • Class Antivirals; Immunoglobulin Fc fragments; Immunoglobulin fusion proteins; Recombinant fusion proteins
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued COVID 2019 infections

Most Recent Events

  • 15 Apr 2022 Hengenix Biotech completes a phase I pharmacokinetic trial for COVID-2019 infections (In volunteers) in the US (NCT04583228)
  • 15 Dec 2021 Discontinued - Phase-I for COVID-2019 infections (In volunteers) in USA (IV) (Shanghai Henlius Biotech pipeline; December 2021)
  • 15 Dec 2021 Discontinued - Preclinical for COVID-2019 infections (Prevention) in China (IV) (Shanghai Henlius Biotech pipeline; December 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top